Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis | Zendy

Rafael F. Duarte | Zendy; Isabel SánchezOrtega | Zendy; Isabel Cuesta | Zendy; Montserrat Arnán | Zendy; Belén Patiño | Zendy; Alberto Fernández de Sevilla | Zendy; Carlota Gudiol | Zendy; Josefina Ayats | Zendy; Manuel CuencaEstrella | Zendy

Open Access

Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis

Author(s) -

Rafael F. Duarte,

Isabel SánchezOrtega,

Isabel Cuesta,

Montserrat Arnán,

Belén Patiño,

Alberto Fernández de Sevilla,

Carlota Gudiol,

Josefina Ayats,

Manuel CuencaEstrella

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu673

Subject(s) - galactomannan , aspergillosis , medicine , posaconazole , hematology , asymptomatic , context (archaeology) , incidence (geometry) , predictive value of tests , gastroenterology , surgery , immunology , antifungal , dermatology , itraconazole , biology , optics , paleontology , physics

There is a practical need to investigate the performance of the serum galactomannan (GM) assay in hematology patients with a potentially low pretest risk of invasive aspergillosis following effective antimold prophylaxis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research